Literature DB >> 21040161

Review: Complement and its regulatory proteins in kidney diseases.

Allison M Lesher1, Wen-Chao Song.   

Abstract

Complement is a part of the body's innate immune system that helps defend the host from microbial infection. It is tightly controlled by a number of cell surface and fluid-phase proteins so that under normal circumstances injury to autologous tissues is avoided. In many pathological settings, such as when the complement regulatory mechanisms are dysfunctional or overwhelmed, complement attack of autologous tissues can occur with severe, sometimes life-threatening consequences. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury and many kidney pathologies have been linked to abnormal complement activation. Clinical and experimental studies have shown that complement attack can be a primary cause in rare, genetically predisposed kidney diseases or a significant contributor to kidney injury caused by other etiological factors. Here we provide a brief review of recent advances on the activation and regulation of the complement system in kidney disease, with a particular emphasis on the relevance of complement regulatory proteins.
© 2010 The Authors. Nephrology © 2010 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21040161      PMCID: PMC4030405          DOI: 10.1111/j.1440-1797.2010.01373.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  127 in total

1.  An integrated map of the human regulator of complement activation (RCA) gene cluster on 1q32.

Authors:  S Rodríguez de Córdoba; M A Díaz-Guillén; D Heine-Suñer
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

Review 2.  Transmembrane channel-formation by five complement proteins.

Authors:  H J Müller-Eberhard
Journal:  Biochem Soc Symp       Date:  1985

Review 3.  Immunomodulatory functions of murine CR1/2.

Authors:  J Prechl; A Erdei
Journal:  Immunopharmacology       Date:  2000-08

4.  Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.

Authors:  Jean-Claude Davin; Valentina Gracchi; Antonia Bouts; Jaap Groothoff; Lisa Strain; Tim Goodship
Journal:  Am J Kidney Dis       Date:  2009-10-25       Impact factor: 8.860

5.  Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo.

Authors:  Heiko Pfister; Markus Ollert; Leopold F Fröhlich; Leticia Quintanilla-Martinez; Thomas V Colby; Ulrich Specks; Dieter E Jenne
Journal:  Blood       Date:  2004-05-18       Impact factor: 22.113

6.  C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack.

Authors:  Leendert A Trouw; Anders A Bengtsson; Kyra A Gelderman; Björn Dahlbäck; Gunnar Sturfelt; Anna M Blom
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

Review 7.  Dense deposit disease: new insights.

Authors:  Patrick D Walker
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-05       Impact factor: 2.894

8.  Novel targets for immunotherapy in glomerulonephritis.

Authors:  Mary H Foster
Journal:  Biologics       Date:  2008-09

9.  The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

Authors:  Viviana P Ferreira; Andrew P Herbert; Claudio Cortés; Kristi A McKee; Bärbel S Blaum; Stefan T Esswein; Dusan Uhrín; Paul N Barlow; Michael K Pangburn; David Kavanagh
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

10.  Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.

Authors:  Matthew C Pickering; Elena Goicoechea de Jorge; Rubén Martinez-Barricarte; Sergio Recalde; Alfredo Garcia-Layana; Kirsten L Rose; Jill Moss; Mark J Walport; H Terence Cook; Santiago Rodriguez de Córdoba; Marina Botto
Journal:  J Exp Med       Date:  2007-05-21       Impact factor: 14.307

View more
  11 in total

1.  Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia.

Authors:  Yoshiyasu Ueda; Takashi Miwa; Damodar Gullipalli; Sayaka Sato; Daisuke Ito; Hangsoo Kim; Matthew Palmer; Wen-Chao Song
Journal:  J Am Soc Nephrol       Date:  2018-06-01       Impact factor: 10.121

2.  Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.

Authors:  Jean F Regal; Megan E Strehlke; Jenna M Peterson; Cameron R Wing; Jordan E Parker; Noel Fernando Nieto; Lynne T Bemis; Jeffrey S Gilbert; Sherry D Fleming
Journal:  Mol Immunol       Date:  2016-08-30       Impact factor: 4.407

3.  Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.

Authors:  Jing Miao; Allison M Lesher; Takashi Miwa; Sayaka Sato; Damodar Gullipalli; Wen-Chao Song
Journal:  Kidney Int       Date:  2014-05-21       Impact factor: 10.612

4.  Expression levels of complement regulatory proteins (CD35, CD55 and CD59) on peripheral blood cells of patients with chronic kidney disease.

Authors:  Dalia Mahmoud Eldewi; Alshaymaa M Alhabibi; Hanaa Mohammed Eid El Sayed; Sammar Ahmed Kasim Mahmoud; Sanaa Mohammed El Sadek; Rasha Mahmoud Gouda; Mohammed Abd El Malik Hassan; Amal H Ibrahim; Naglaa F Abd El Haliem
Journal:  Int J Gen Med       Date:  2019-09-16

5.  Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells.

Authors:  Jing-Min Zheng; Sha-Sha Wang; Xiong Tian; De-Jun Che
Journal:  Mol Med Rep       Date:  2020-10-22       Impact factor: 2.952

Review 6.  Complement as a Therapeutic Target in Systemic Autoimmune Diseases.

Authors:  María Galindo-Izquierdo; José Luis Pablos Alvarez
Journal:  Cells       Date:  2021-01-13       Impact factor: 6.600

7.  A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia-reperfusion injury.

Authors:  Anjan K Bongoni; Ingela B Vikstrom; Jennifer L McRae; Evelyn J Salvaris; Nella Fisicaro; Martin J Pearse; Sandra Wymann; Tony Rowe; Adriana Baz Morelli; Matthew P Hardy; Peter J Cowan
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

Review 8.  Overview of complement activation and regulation.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

9.  Decay-accelerating factor 1 deficiency exacerbates leptospiral-induced murine chronic nephritis and renal fibrosis.

Authors:  María F Ferrer; Emilia Scharrig; Lucrecia Alberdi; Maia Cedola; Gabriela Pretre; Ricardo Drut; Wen-Chao Song; Ricardo M Gomez
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

Review 10.  Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review.

Authors:  Taylor J Louis; Ahmad Qasem; Latifa S Abdelli; Saleh A Naser
Journal:  Microorganisms       Date:  2022-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.